2.40
2.40 (0%)
As of Apr 17, 2025
Terns Pharmaceuticals, Inc. [TERN]
Source:
Company Overview
Terns Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity.
| Country | United States |
| Headquarters | foster city, california |
| Phone Number | (650) 525-5535 |
| Industry | manufacturing |
| CEO | Amy Burroughs |
| Website | www.ternspharma.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | |
| Operating Profit | $-101.9 |
| Net Income | $-88.9 |
| Net Cash | $81.5 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -28.1% |
| Profit as % of Stockholder Equity | -25.7% |
Management Effectiveness
| Return on Equity | -25.7% |
| Return on Assets | -24.4% |
| Turnover Ratio | |
| EBITA | $-101.9 |
Balance Sheet and Cash Flow Measures
| Total Assets | $363.9 |
| Total Liabilities | $18.1 |
| Operating Cash Flow | $-70 |
| Investing Cash Flow | $-12.4 |
| Financing Cash Flow | $164 |
